Skye Bioscience, Inc. Annual report pursuant to Section 13 and 15(d)

Other Current Liabilities

12 Months Ended

Dec. 31, 2020

9. Other Current Liabilities

Other current liabilities consist of the following:

	As of December 31,
	2020		2019
Accrued payroll liabilities		61,547		43,830
Accrued research and development costs		93,888		148,006
Accrued legal expense		57,596		92,237
Accrued board fees		40,625		58,395
Total other accrued liabilities		5,455		77,938
	$	259,111	$	420,406